Company: CMND
Filing Date: 2025-10-31
Form Type: 6-K
Source: 0001213900-25-104396
Chunk: 0

Company: Clearmind Medicine Inc.
Filing Date: 2025-10-31
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of: October 2025

Commission file number: 001-41557

CLEARMIND MEDICINE INC.

(Translation of registrant’s name into English)

101 – 1220 West 6th Avenue

Vancouver, British Columbia

(Address of principal executive offices)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒
Form 40-F ☐

CONTENTS</div>

Attached
hereto and incorporated herein is Clearmind Medicine Inc.’s (the “Company”) press release issued on October 31,
2025, titled “Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its
Non-Hallucinogenic Neuroplastogen MEAI Therapy”.

In addition, as previously announced, on September 17, 2025, the Company entered into a definitive
securities purchase agreements with investors pursuant to which the Company shall issue and sell, from time to time, convertible promissory
notes (the “Notes”) in the aggregate principal amount of up to $10,000,000. On October 30, 2025 and October 31, 2025, an aggregate
of $1,045,062 of outstanding amounts due under the Notes were converted into 885,000 of the Company’s common shares.

This Form 6-K and the first
three paragraphs of the press release attached to this Form 6-K as Exhibit 99.1 are incorporated by reference into the
Registrant’s Registration Statements on Form F-3 (File Nos. 333-275991, 333-270859, 333-273293)
and Form S-8 (File No. 333-283695),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the
extent not superseded by documents or reports subsequently filed or furnished.

<div align='center'>1

EXHIBIT INDEX</div>

| Exhibit No. |     |